Navigation Links
'Seena' clinical trials named for pancreatic cancer advocate
Date:12/1/2011

all drugs combined. Patients will be given this treatment for a maximum of 6 months.
  • In the third treatment, the patient's tumor will be biopsied and analyzed using molecular profiling to determine the next most appropriate treatment. Patients also will receive a drug called Metformin during this part of the study.

    The plan is to attack all components of the cancer: the tumor cell, their support structure and their energy source.

    The clinical trial sites includes the Virginia G. Piper Cancer Center Clinical Trials, a partnership of TGen and Scottsdale Healthcare, where the principal investigator is TGen Physician-In-Chief Dr. Daniel Von Hoff, one of the world's leading authorities on pancreatic cancer. Dr. Von Hoff also is chief scientific officer at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.

    Dr. Von Hoff said that TGen, through the Virginia G. Piper Cancer Center at Scottsdale Healthcare and its other PCRT partners, are making progress in the quest to end this cancer: "We are to deliver a knockout punch by combining the best treatments we have against the disease. The contributions of Roger Magowitz represent significant acceleration toward our goal of finding better treatments, and ultimately a cure."

    The other clinical trial sites are:

    Virginia Piper Cancer Institute, Minneapolis, Minn., where the principal investigator is Dr. John Seng: "We are one of the nation's leading pancreatic cancer treatment centers. The new Seena clinical trial will allow patients to take a more active role in their health care, gain access to new drugs, treatments and disease management practices, and contribute to medical research."

    Evergreen Hematology & Oncology, Spokane, Wash., where the principal investigator is Dr. Stephen Anthony: "As the former Chief Medical Officer of TGen Drug Development, I know how meticulously this study will be organized and conducted, using every efficiency possi
    '/>"/>


  • Contact: Steve Yozwiak
    syozwiak@tgen.org
    602-343-8704
    The Translational Genomics Research Institute
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Vaccine targeting latent TB enters clinical testing
    2. Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy
    3. BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
    4. Heart rate recovery predicts clinical worsening in pulmonary hypertension
    5. Worlds first stem cell bandage in human clinical trials
    6. Combination therapy shows potent tumor growth inhibition in preclinical studies
    7. CBIs Interactive Response Technologies for Clinical Trials - the Only IVR/IWR Event of Its Kind - Will Be in Philadelphia on November 14-15, 2011
    8. Study shows that new DNA test to identify Down syndrome in pregnancy is ready for clinical use
    9. Professor Peter J. Coffeys stem cell therapy for Age-Related Macular Degeneration expected to begin clinical trials in 2012
    10. AMIA advises FDA on clinical decision support
    11. Reports highlight the evolving role of clinical microbiology laboratories
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
    (Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
    (Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
    Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
    ... a fatal genetic disorder called Krabbe Disease can be saved ... from umbilical cord blood before symptoms of the disease develop, ... issue of the New England Journal of Medicine. , Without ... to lose all cognitive and motor functions and die by ...
    ... new 250 million year-old species of large, meat-eating ... from McGill University. Their findings published in today's ... amphibious carnivores from the Republic of Niger in ... carnivores in this area," says McGill paleontologist, and ...
    ... the hair at the back of the man's head gets ... lesser hair loss. There are hardly any successful counter-measures ?despite ... has long been suspected that hereditary factors are important in ... which genes are involved. The researchers in the team headed ...
    Cached Biology News:Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells 2Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells 3Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells 4Tendency to hair loss inherited from the mother 2
    (Date:5/6/2015)... May 06, 2015 Follow ... type of nanomaterial with diameter ranging between 2 ... the global nanophotonics materials market. The unique electroluminescent, ... due to quantum confinement effect render the nanoparticles ... range of scientific, technological, and commercial applications. A ...
    (Date:5/6/2015)... 06, 2015 Tenney, a Thermal Product ... of standard and custom environmental test chambers ... engineering and design, robust construction, and superior performance, the ... meet all of your temperature, humidity, altitude, vibration, and ... of the TPS Smart 1.0 Controller. The Smart 1.0 ...
    (Date:5/6/2015)... , May 6, 2015   University of Maryland ... announced today the signing of an exclusive option by ... Baltimore (UMB) to develop diagnostics to detect inflammatory bowel ... disease (CD). Drs. Florian Fricke and ... were with the University of Maryland School of Medicine,s ...
    (Date:5/6/2015)... , May 6, 2015  Northwest Biotherapeutics (NASDAQ: NWBO) ... therapies for solid tumor cancers, today announced that Linda Powers ... the Company,s DCVax cancer vaccine platform for solid tumor cancers ... 7, 2015.   , , , ... , , , TIME: , , , 12:15 PM EDT ...
    Breaking Biology Technology:Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3The TPS 3.5” Smart 1.0 Controller Raises the Tech Standard on Environmental Test Chambers 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 2NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7 3
    ... At a meeting of its,Board of Directors, held today, ... and Preferred Stock of the Company., A dividend of ... Stock was declared payable on September 2, 2008 to,stockholders of ... In addition, a dividend of fifty cents ($.50) per ...
    ... - Offers Businesses New Flexibility for Pandemic Planning -, ... the,introduction of a flexible purchase program that will allow ... Tamiflu(R) for use in a,pandemic situation, with limited upfront ... in pandemic planning., Under the new plan, businesses ...
    ... Therapeutics,Inc. (OTC Bulletin Board: DSKA.OB) ("Duska" or the ... via Standard & Poor,s,Corporation Records Listing Program. As ... Therapeutics is published in the Daily News section ... secondary,trading in approximately 38 states under the Blue ...
    Cached Biology Technology:Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 2Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 4Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 5Duska Therapeutics Obtains Standard & Poor's Listing 2
    Mol wt: average mol wt12,360.96 Da by calculation...
    Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
    ... Adaptor encodes a T7 promoter, lac ... translation initation codon and an N-terminal GST•Tag ... reported to enhance the production and in ... partners. The GST•Tag is a multi-purpose tag ...
    A cost-effective serum for general cell growth requirements. All serum is collected from calves aged 10 days old or less....
    Biology Products: